News
US Plans to Test Medicare, Medicaid Coverage for Weight-Loss Drugs, Washington Post Reports
According to the Washington Post, 13 states currently cover the drugs for Medicaid patients, while Medicare prohibits coverage of the drugs used solely for weight loss, but allows for treating indications they are approved for like sleep apnea and heart disease.
A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.
The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback